Functional outcome and quality of life in adult congenital heart disease patients with prosthetic valves*

Completed

• Conditions: prosthetic heart valves in congenital heart disease; 10010394; 10007510; 10007593

• Registration Number: NL-OMON32722
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 600

Inclusion Criteria

Included in concor database, congenital heart disease, valve prosthesis 9all required)

Exclusion Criteria

Inability to comply with examinations (quality of life questionnaire and exercise test)

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcomes are VO2max and quality of life.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes are the prevalence of PPM and the incidence of valve related<br /><br>complications.</p><br>